Key Biosimilar Regulatory Milestones
The development and registration of biosimilars are complex processes that involve numerous regulatory milestones. These milestones are critical to ensuring […]
General Biotechnology
General Biotechnology
New tentative approval for Alembic drug dabigatran etexilate mesylate
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
Infographic
Which pharmaceutical drugs have the most patents?
This chart shows the pharmaceutical drugs with the greatest number of patents still in force. The number of patents covering […]
Source
Which pharmaceutical drugs have the most patents? Read Post »
Resources
Scaling Up Excipient Production in Your Facility: A Comprehensive Guide
Scaling up excipient production is a critical step for pharmaceutical manufacturers aiming to meet increasing market demands while maintaining product quality and regulatory compliance. This process involves numerous challenges and requires meticulous …
Scaling Up Excipient Production in Your Facility: A Comprehensive Guide Read Post »
General Biotechnology
The Future of Biomanufacturing: Trends and Innovations
Biomanufacturing, a revolutionary approach to sustainability and responsibility, harnesses the power of engineered microorganisms to create valuable products with desirable
The Future of Biomanufacturing: Trends and Innovations Read Post »
Insights
Navigating Patent Opposition in Drug Patenting: A Comprehensive Guide
Introduction Patent oppositions are a crucial tool in the pharmaceutical industry, allowing civil society to challenge the validity of patents […]
Source
Navigating Patent Opposition in Drug Patenting: A Comprehensive Guide Read Post »
Patent Added
New patent for Alcon Labs drug ROCKLATAN
Annual Drug Patent Expirations for ROCKLATAN Rocklatan is a drug marketed by Alcon Labs Inc and is included in one […]
Source
Patent Added
New patent for Alcon Labs drug RHOPRESSA
Annual Drug Patent Expirations for RHOPRESSA Rhopressa is a drug marketed by Alcon Labs Inc and is included in one […]
Source
Uncategorized
New patent expiration for Hatchtech drug XEGLYZE
Annual Drug Patent Expirations for XEGLYZE Xeglyze is a drug marketed by Hatchtech and is included in one NDA. It […]
Source
New patent expiration for Hatchtech drug XEGLYZE Read Post »
Tentative Approval
New tentative approval for Alembic drug dabigatran etexilate mesylate
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
